| Source: |
| Type: measurement |
| Bioavailability (usually in %) absorbed by the body. |
| Normal Healthy |
| 5272- | 3BP, | The efficacy of the anticancer 3-bromopyruvate is potentiated by antimycin and menadione by unbalancing mitochondrial ROS production and disposal in U118 glioblastoma cells |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | Nor, | HEK293 |
| 4600- | AgNPs, | Effects of particle size and coating on toxicologic parameters, fecal elimination kinetics and tissue distribution of acutely ingested silver nanoparticles in a mouse model |
| - | in-vivo, | Nor, | NA |
| 4598- | AgNPs, | In vivo human time-exposure study of orally dosed commercial silver nanoparticles |
| - | in-vivo, | Nor, | NA |
| 4594- | AgNPs, | Citrate, | Bioavailability and Toxicokinetics of citrate-coated silver nanoparticles in rats |
| - | in-vivo, | Nor, | NA |
| 5165- | AL, | The human allicin-proteome: S-thioallylation of proteins by the garlic defence substance allicin and its biological effects |
| - | in-vitro, | AML, | Jurkat | - | in-vitro, | Nor, | L929 |
| 1152- | Api, | Does Oral Apigenin Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers? |
| - | Analysis, | Nor, | NA |
| 2570- | ART/DHA, | Discovery, mechanisms of action and combination therapy of artemisinin |
| - | Review, | Nor, | NA |
| 5417- | ASTX, | Comparative Pharmacokinetic Study of Standard Astaxanthin and its Micellar Formulation in Healthy Male Volunteers |
| - | Study, | Nor, | NA |
| - | in-vivo, | Nor, | NA |
| 5423- | ASTX, | Pharmacokinetic Profile of Astaxanthin Nanoemulsion Using HPLC (High-Performance Liquid Chromatography) With Oral Routes |
| - | in-vivo, | Nor, | NA |
| 5445- | ATV, | Atorvastatin |
| - | NA, | Nor, | NA |
| 5572- | B-Gluc, | The Effects of Orally Administered Beta-Glucan on Innate Immune Responses in Humans, a Randomized Open-Label Intervention Pilot-Study |
| - | Study, | Nor, | NA |
| 5496- | Ba, | A strategy to improve the oral availability of baicalein: The baicalein-theophylline cocrystal |
| - | in-vivo, | Nor, | NA |
| 5642- | BCA, | Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: in vitro and in vivo |
| - | vitro+vivo, | Nor, | NA |
| 5655- | BNL, | Comparative pharmacokinetic studies of borneol in mouse plasma and brain by different administrations |
| - | in-vivo, | Nor, | NA |
| 1646- | CA, | Caffeic acid: a brief overview of its presence, metabolism, and bioactivity |
| - | Review, | Nor, | NA |
| 5858- | CAP, | Capsaicin as a Microbiome Modulator: Metabolic Interactions and Implications for Host Health |
| - | Review, | Nor, | NA | - | Review, | AD, | NA |
| 5881- | CAR, | Carvacrol—A Natural Phenolic Compound with Antimicrobial Properties |
| - | Review, | Nor, | NA |
| 5878- | CAR, | TV, | Metabolism in rats of p-cymene derivatives: carvacrol and thymol |
| - | in-vivo, | Nor, | NA |
| 5928- | Catechins, | Bioavailability of Tea Catechins and Its Improvement |
| - | Review, | Nor, | NA |
| 6004- | CGA, | Dose-response plasma appearance of coffee chlorogenic and phenolic acids in adults |
| - | Human, | Nor, | NA |
| 6011- | CGA, | Chlorogenic Acid’s Role in Metabolic Health: Mechanisms and Therapeutic Potential |
| - | Review, | Nor, | NA |
| 6081- | CHL, | Enhancing Health Benefits through Chlorophylls and Chlorophyll-Rich Agro-Food: A Comprehensive Review |
| - | Review, | Nor, | NA |
| 2809- | CUR, | Comparative absorption of curcumin formulations |
| - | in-vivo, | Nor, | NA |
| 1608- | EA, | Ellagic Acid from Hull Blackberries: Extraction, Purification, and Potential Anticancer Activity |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | HUVECs |
| 5227- | EMD, | Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy |
| - | vitro+vivo, | Nor, | NA |
| 1638- | HCAs, | Anticancer potential of hydroxycinnamic acids: mechanisms, bioavailability, and therapeutic applications |
| - | Review, | Nor, | NA |
| 2079- | HNK, | Honokiol Microemulsion Causes Stage-Dependent Toxicity Via Dual Roles in Oxidation-Reduction and Apoptosis through FoxO Signaling Pathway |
| - | in-vitro, | Nor, | PC12 |
| 3528- | Lyco, | The Importance of Antioxidant Activity for the Health-Promoting Effect of Lycopene |
| - | Review, | Nor, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
| 3251- | PBG, | The Antioxidant and Anti-Inflammatory Effects of Flavonoids from Propolis via Nrf2 and NF-κB Pathways |
| - | Review, | AD, | NA | - | Review, | Diabetic, | NA | - | Review, | Var, | NA | - | in-vitro, | Nor, | H9c2 |
| 2964- | PL, | Preformulation Studies on Piperlongumine |
| - | Analysis, | Nor, | NA |
| 2442- | RES, | High absorption but very low bioavailability of oral resveratrol in humans |
| - | in-vitro, | Nor, | NA |
| 3099- | RES, | Resveratrol and cognitive decline: a clinician perspective |
| - | Review, | Nor, | NA | - | NA, | AD, | NA |
| 2447- | SFN, | Sulforaphane Bioavailability from Glucoraphanin-Rich Broccoli: Control by Active Endogenous Myrosinase |
| - | Review, | Nor, | NA |
| 3291- | SIL, | Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases |
| - | Review, | Nor, | NA |
| 4131- | Silicon, | Silicon reduces aluminum accumulation in rats: relevance to the aluminum hypothesis of Alzheimer disease |
| - | Study, | Nor, | NA |
| 5335- | TFdiG, | Microbial Metabolism of Theaflavin-3,3′-digallate and Its Gut Microbiota Composition Modulatory Effects |
| - | in-vivo, | Nor, | NA |
| 1937- | TQ, | Migration and Proliferation Effects of Thymoquinone-Loaded Nanostructured Lipid Carrier (TQ-NLC) and Thymoquinone (TQ) on In Vitro Wound Healing Models |
| - | NA, | Nor, | 3T3 |
| 4860- | Uro, | Urolithins–gut Microbial Metabolites with Potential Health Benefits |
| - | Review, | Nor, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:792 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid